Measurement of a malondialdehyde-DNA adduct
1Vanderbilt University, Nashville, Tennessee, USA.
Current Protocols in Toxicology
|October 14, 2010
Summary
This study details methods for measuring DNA adducts, specifically those formed by malondialdehyde, a carcinogen. These measurements help understand carcinogen toxicology and biological effects.
Area of Science:
- Toxicology
- Biochemistry
- Analytical Chemistry
Background:
- DNA adducts are key biomarkers for carcinogen exposure and mutagenic effects.
- Malondialdehyde (MDA) is an endogenous electrophile linked to cancer and mutagenicity.
- Quantifying DNA adducts provides a direct measure of biologically effective dose.
Purpose of the Study:
- To establish methods for detecting and quantifying DNA adducts formed by malondialdehyde.
- To enable the study of malondialdehyde's toxicological mechanisms and biological impact.
- To provide tools for assessing exposure to this carcinogenic electrophile.
Main Methods:
- Development of an assay for detecting malondialdehyde-deoxyguanosine adducts.
- Utilizing gas chromatographic/negative chemical ionization-electron capture mass spectrometry for sensitive detection.
- Preparation of immunoaffinity gels and High-Performance Liquid Chromatography (HPLC) for nucleoside quantification.
Main Results:
- Successful detection of a fluorescent pyrimidopurinone adduct formed by malondialdehyde and deoxyguanosine.
- Established protocols for preparing specific immunoaffinity gels for adduct isolation.
- Validated HPLC methods for accurate quantification of nucleosides.
Conclusions:
- Direct measurement of DNA adducts, like those from malondialdehyde, is crucial for toxicology.
- The developed methods allow for sensitive detection and quantification of specific mutagenic adducts.
- This work provides essential tools for assessing carcinogen exposure and mechanisms.
More Related Videos
06:19Evaluation of Oxidative Stress in Biological Samples Using the Thiobarbituric Acid Reactive Substances Assay
Published on: May 12, 2020
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
